BrightSpring Health Services (BTSG) Set to Announce Quarterly Earnings on Thursday

BrightSpring Health Services (NASDAQ:BTSG) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.06 per share for the quarter. BrightSpring Health Services has set its FY 2024 guidance at EPS.Investors that wish to register for the company’s conference call can do so using this link.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings data on Thursday, February 29th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.21). The firm had revenue of $2.38 billion for the quarter, compared to analyst estimates of $2.36 billion. The firm’s revenue was up 20.5% compared to the same quarter last year. On average, analysts expect BrightSpring Health Services to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

BrightSpring Health Services Trading Up 3.1 %

NASDAQ BTSG opened at $10.91 on Tuesday. BrightSpring Health Services has a 12 month low of $7.85 and a 12 month high of $12.14. The company’s 50 day moving average is $9.86. The company has a current ratio of 1.17, a quick ratio of 0.84 and a debt-to-equity ratio of 5.73.

Insider Transactions at BrightSpring Health Services

In other news, insider James F. Mattingly, Jr. acquired 12,280 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $8.18 per share, with a total value of $100,450.40. Following the purchase, the insider now owns 128,700 shares of the company’s stock, valued at approximately $1,052,766. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other BrightSpring Health Services news, insider James F. Mattingly, Jr. purchased 12,280 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The shares were purchased at an average cost of $8.18 per share, with a total value of $100,450.40. Following the completion of the transaction, the insider now owns 128,700 shares of the company’s stock, valued at $1,052,766. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Jennifer A. Phipps acquired 12,300 shares of BrightSpring Health Services stock in a transaction that occurred on Thursday, March 14th. The stock was acquired at an average cost of $8.14 per share, with a total value of $100,122.00. Following the completion of the purchase, the chief accounting officer now owns 165,618 shares in the company, valued at approximately $1,348,130.52. The disclosure for this purchase can be found here.

Wall Street Analysts Forecast Growth

BTSG has been the topic of a number of research reports. Wells Fargo & Company assumed coverage on BrightSpring Health Services in a research note on Tuesday, February 20th. They issued an “overweight” rating and a $15.00 price objective on the stock. UBS Group started coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued a “buy” rating and a $15.00 price target for the company. Leerink Partnrs reaffirmed an “outperform” rating on shares of BrightSpring Health Services in a research note on Tuesday, February 20th. Bank of America started coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued a “buy” rating and a $14.00 target price on the stock. Finally, The Goldman Sachs Group reduced their target price on shares of BrightSpring Health Services from $26.00 to $23.00 and set a “buy” rating for the company in a report on Monday, March 4th. Eleven research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $15.75.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.